Universal Ibogaine Inc. (IBO.V)

0.0200 0.0000 (0.00%) As of 10:18AM EDT. Market open.

Universal Ibogaine Inc.

815 8th Avenue SW
Suite 600
Calgary, AB T2P 3P2
Canada
855-426-4246
https://universalibogaine.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Nicholas Peter Karos	CEO, Director of Capital Markets & Director	240k	N/A	N/A
Mr. Greg J. Leavens C.A., CPA	CFO & Corporate Secretary	175k	N/A	1965
Mr. Shayne Nyquvest	Co-Founder	231.08k	N/A	N/A
Mr. Dugan Selkirk	Manager Communications & Investor Relations	N/A	N/A	N/A
Cathy Fernandes	VP of Marketing & VP of Communications	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada. It undertakes planned clinical trial for research into the use of ibogaine for addiction treatment. The company is headquartered in Calgary, Canada.

Corporate Governance

Universal Ibogaine Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.